Get started
Author

Eric J. Arts

Observed names: ARTS, Eric, Arts, Eric, Arts, Eric J, Arts, Eric J., Arts, Eric Joseph, E ARTS, E Arts, E J Arts, E. J. Arts, E.J. Arts, EJ Arts, Eric J. Arts, Eric Arts, Eric J Arts, Eric J. ARTS, Eric J. Arts
Observed institutions: University of Geneva, Scripps Research Institute, Western University, National Institutes of Health, Howard Hughes Medical Institute, Harvard University, Johns Hopkins University, University Hospitals of Cleveland, Jewish General Hospital, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, University Hospitals Cleveland Medical Center, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Joint Clinical Research Centre, Lady Davis Institute for Medical Research, McGill University, Case Western Reserve University
ORCID: 0000-0002-4880-7968
Observed ORCID: 0000-0002-4880-7968
OpenAlex ID: A5074401742
HIV-1 Antiretroviral Drug Therapy
2012 · E. J. Arts, D. J. Hazuda · Cold Spring Harbor Perspectives in Medicine · 852
PDF
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
2008 · Toshiyuki Miura, Mark A. Brockman, et al. · Journal of Virology · 295
Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
2010 · Denis M Tebit, Eric J Arts · The Lancet Infectious Diseases · 280
A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression
2000 · Miguel E. Quiñones-Mateu, Sarah C. Ball, et al. · Journal of Virology · 234
The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates
2005 · Kevin K. Ariën, Awet Abraha, et al. · Journal of Virology · 223
PDF
Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C
2002 · Sarah C. Ball, Awet Abraha, et al. · Journal of Virology · 202
Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression
2005 · Ryan M. Troyer, Kalonji R. Collins, et al. · Journal of Virology · 200
Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response
2009 · Ryan M. Troyer, John McNevin, et al. · PLoS Pathogens · 196
PDF
Is HIV-1 evolving to a less virulent form in humans?
2007 · Kevin K. Ariën, Guido Vanham, et al. · Nature Reviews Microbiology · 189
PDF
Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site
1996 · X Li, Y Quan, et al. · Journal of Virology · 132
Impact of tuberculosis on HIV-1 replication, diversity, and disease progression.
2003 · Kalonji R Collins, Miguel E Quiñones-Mateu, et al. · PubMed · 128
Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication
1994 · X Li, J Mak, et al. · Journal of Virology · 118
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription
1996 · E J Arts, M A Wainberg · Antimicrobial Agents and Chemotherapy · 116
Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.
1994 · E.J. Arts, X. Li, et al. · Journal of Biological Chemistry · 114
PDF
Differences in the Fitness of Two Diverse Wild-Type Human Immunodeficiency Virus Type 1 Isolates Are Related to the Efficiency of Cell Binding and Entry
2005 · Andre J. Marozsan, Dawn M. Moore, et al. · Journal of Virology · 105
CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic
2009 · Awet Abraha, Immaculate L. Nankya, et al. · Journal of Virology · 104
Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
2009 · Kara G. Lassen, Michael A. Lobritz, et al. · PLoS Pathogens · 102
PDF
Relationships between Infectious Titer, Capsid Protein Levels, and Reverse Transcriptase Activities of Diverse Human Immunodeficiency Virus Type 1 Isolates
2004 · Andre J. Marozsan, Erika Fraundorf, et al. · Journal of Virology · 102
HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?
2007 · Denis M Tebit, Immaculate Nankya, et al. · PubMed · 100
A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains
2009 · Samantha. H. Johnston, Michael A. Lobritz, et al. · Journal of Virology · 99
The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2', 3'-dideoxycytidine, 2',3'-dideoxy-3'-thiacytidine, and 2',3'-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro.
1994 · Z Gu, R S Fletcher, et al. · Journal of Biological Chemistry · 99
Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape
2007 · Yi Liu, John McNevin, et al. · Journal of Virology · 98
Restoration of tRNA -primed( )-Strand DNA Synthesis to an HIV-1 Reverse Transcriptase Mutant with Extended tRNAs
1996 · Eric J. Arts, Madhumita Ghosh, et al. · Journal of Biological Chemistry · 98
Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection
2010 · Charles S Morrison, Korey Demers, et al. · AIDS · 90
Fitness of drug resistant HIV-1: methodology and clinical implications
2002 · Miguel E Quiñones-Mateu, Eric J Arts · Drug Resistance Updates · 90
Works count: 253
Citation count: 8,298
H-index: 51
I10-index: 133
Year
Topic
Type